NCT06588413View on ClinicalTrials.gov

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

PHASE3RecruitingINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Multiple MyelomaAutologous Stem Cell Transplantation
Interventions
DRUG

Olanzapine

Subjects will be randomized to either olanzapine 2.5 mg or 5 mg

Trial Locations (1)

30912

RECRUITING

Wellstar MCG, Augusta

All Listed Sponsors
lead

Augusta University

OTHER